Profil
Antonio Sfiligoj is the founder of Italian Angels for Growth, which was founded in 2007.
He is currently the Chief Executive Officer of Nanoxer Srl and a Senior Adviser at Advicorp Plc.
Aktive Positionen von Antonio Sfiligoj
| Unternehmen | Position | Beginn |
|---|---|---|
Advicorp Plc
Advicorp Plc Investment Banks/BrokersFinance Provides investment banking and securities brokerage services | Corporate Officer/Principal | 25.07.2011 |
Nanoxer Srl
Nanoxer Srl Construction MaterialsNon-Energy Minerals Develops and manufactures aerogel-containing insulation materials | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Antonio Sfiligoj
| Unternehmen | Position | Ende |
|---|---|---|
Italian Angels for Growth
Italian Angels for Growth Investment ManagersFinance Italian Angels for Growth invests in European and North American startups particularly located in Italy, United Kingdom and the United Stages. The firm target companies operating in the field of fintech, industrial & energy, information technology and life sciences with an investment size between EUR 0.2 to EUR 1.4 million. It provides financing for early stage capital requirements. | Gründer | 01.07.2011 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Nanoxer Srl
Nanoxer Srl Construction MaterialsNon-Energy Minerals Develops and manufactures aerogel-containing insulation materials | Non-Energy Minerals |
Advicorp Plc
Advicorp Plc Investment Banks/BrokersFinance Provides investment banking and securities brokerage services | Finance |
Italian Angels for Growth
Italian Angels for Growth Investment ManagersFinance Italian Angels for Growth invests in European and North American startups particularly located in Italy, United Kingdom and the United Stages. The firm target companies operating in the field of fintech, industrial & energy, information technology and life sciences with an investment size between EUR 0.2 to EUR 1.4 million. It provides financing for early stage capital requirements. | Finance |
















